Clinical Trial Update: Evaluation of the Effects of Duloxetine on Norepinephrine [Phase 1]

View source ↗

Summary

This trial update reports the completion of a Phase 1 study evaluating the effects of duloxetine on norepinephrine in adults with Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED